RISK OF LIFE-THREATENING ARRHYTHMIC EVENTS IN NON-ISCHEMIC HEART FAILURE PATIENTS WITH PROPHYLACTIC CARDIOVERTER DEFIBRILLATOR

Concerns about the efficacy of prophylactic implantable cardioverter defibrillator (ICD) in non-ischemic (N-I) heart failure (HF) patients (p) remain, especially after DANISH trial. However up to 58% of p included, underwent concomitant resynchronization therapy. to assess whether the risk of